Avant Genomics
PrivateLast Round
Seed
May 13, 2026
Total Funding Raised
$3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Avant Genomics is a biotechnology company developing a first-of-its-kind platform that automates liquid biopsy sample preparation for blood-based cancer detection.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avant Genomics Comparables
Compare Avant Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| nRichDX | 85% | |
| Apostle Inc. | 74% | |
| PerkinElmer | 73% |
Avant Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 13, 2026 |
Key People
Founding team and executive leadership
Avant Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Global Impact Fund | Seed |
| CAV Angels | Seed |
| Virginia Innovation Partnership Corporation | Seed |
| Halyard Ventures | Seed |
| Virginia Venture Partners | Seed |
| Global Health Impact Fund | Seed |
| TitletownTech | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 3, 2026
Grew 38% QoQ, from 8 to 11 employees.
- Jul 26, 2026
Monthly visitors increased 43% MoM.
Avant Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Avant Genomics's valuation, stock price, and market status.
Is Avant Genomics a public or private company?
Avant Genomics is a private company.
What is the current stock price of Avant Genomics?
Avant Genomics is a private company with no public stock price. No recent secondary market data is available.
How much is Avant Genomics worth (valuation)?
Valuation information for Avant Genomics is not publicly available.
Can I buy Avant Genomics stock?
Avant Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Avant Genomics's last funding round?
Avant Genomics's most recent funding round was Seed on May 13, 2026.
Who are the main investors in Avant Genomics?
Key investors in Avant Genomics include TitletownTech.
Will Avant Genomics IPO soon?
No public IPO plans have been announced for Avant Genomics.
How can I track Avant Genomics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Avant Genomics's secondary market activity and sign up for updates.